Works about CASTRATION-resistant prostate cancer


Results: 2928
    1
    2
    3
    4
    5
    6
    7

    Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06644-7
    By:
    • Thulin, Malin Hagberg;
    • Ramberg, Håkon;
    • Nielsen, Heidi Kristin;
    • Grytli, Helene Hartvedt;
    • Sivanesan, Shivanthe;
    • Pandya, Abhilash D.;
    • Seip, Kotryna;
    • Andressen, Kjetil Wessel;
    • Linder, Anna;
    • Øijordsbakken, Miriam;
    • Poutanen, Matti;
    • Katz, Betina;
    • Halvorsen, Bente;
    • Mælandsmo, Gunhild Mari;
    • Taskén, Kristin Austlid
    Publication type:
    Article
    8
    9
    10
    11
    12
    14
    15
    16
    17
    18

    Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf107
    By:
    • Conteduca, Vincenza;
    • Scarpi, Emanuela;
    • Rossi, Alice;
    • Ferroni, Fabio;
    • Gurioli, Giorgia;
    • Bleve, Sara;
    • Gianni, Caterina;
    • Schepisi, Giuseppe;
    • Brighi, Nicole;
    • Lolli, Cristian;
    • Cursano, Maria Concetta;
    • Virga, Alessandra;
    • Casadei, Chiara;
    • Altavilla, Amelia;
    • Farolfi, Alberto;
    • Ulivi, Paola;
    • Barone, Domenico;
    • Matteucci, Federica;
    • Giorgi, Ugo De
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4669, doi. 10.3390/ijms26104669
    By:
    • Ortiz, Maria Angels;
    • Anguera, Georgia;
    • Cantó, Elisabet;
    • Alejandre, Jose;
    • Mora, Josefina;
    • Osuna-Gómez, Ruben;
    • Mulet, Maria;
    • Mora, Pradip;
    • Antonijuan, Assumpta;
    • Sánchez, Sofia;
    • Ramírez, Ona;
    • Orantes, Vanessa;
    • Maroto, Pablo;
    • Vidal, Silvia
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.

    Published in:
    NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00854-4
    By:
    • Nauseef, Jones T.;
    • Chu, Timothy R.;
    • Hooper, William F.;
    • Alonso, Alicia;
    • Oku, Ali;
    • Geiger, Heather;
    • Goldstein, Zoe R.;
    • Shah, Minita;
    • Sigouros, Michael;
    • Manohar, Jyothi;
    • Steinsnyder, Zoe;
    • Winterkorn, Lara;
    • Robinson, Brian D.;
    • Sboner, Andrea;
    • Beltran, Himisha;
    • Elemento, Olivier;
    • Hajirasouliha, Iman;
    • Imielinski, Marcin;
    • Nanus, David M.;
    • Tagawa, Scott T.
    Publication type:
    Article
    46

    Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00599-6
    By:
    • Ajkunic, Azra;
    • Sayar, Erolcan;
    • Roudier, Martine P.;
    • Patel, Radhika A.;
    • Coleman, Ilsa M.;
    • De Sarkar, Navonil;
    • Hanratty, Brian;
    • Adil, Mohamed;
    • Zhao, Jimmy;
    • Zaidi, Samir;
    • True, Lawrence D.;
    • Sperger, Jamie M.;
    • Cheng, Heather H.;
    • Yu, Evan Y.;
    • Montgomery, Robert B.;
    • Hawley, Jessica E.;
    • Ha, Gavin;
    • Persse, Thomas;
    • Galipeau, Patricia;
    • Lee, John K.
    Publication type:
    Article
    47

    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00526-9
    By:
    • Walmsley, Charlotte S.;
    • Jonsson, Philip;
    • Cheng, Michael L.;
    • McBride, Sean;
    • Kaeser, Christopher;
    • Vargas, Herbert Alberto;
    • Laudone, Vincent;
    • Taylor, Barry S.;
    • Kappagantula, Rajya;
    • Baez, Priscilla;
    • Richards, Allison L.;
    • Noronha, Anne Marie;
    • Perera, Dilmi;
    • Berger, Michael;
    • Solit, David B.;
    • Iacobuzio-Donahue, Christine A.;
    • Scher, Howard I.;
    • Donoghue, Mark T. A.;
    • Abida, Wassim;
    • Schram, Alison M.
    Publication type:
    Article
    48
    49

    CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis.

    Published in:
    Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02520-4
    By:
    • Mehra, Chahat;
    • Chung, Ji-Hyun;
    • He, Yi;
    • Lara-Márquez, Mónica;
    • Goyette, Marie-Anne;
    • Boufaied, Nadia;
    • Barrès, Véronique;
    • Ouellet, Véronique;
    • Guérard, Karl-Phillippe;
    • Delliaux, Carine;
    • Saad, Fred;
    • Lapointe, Jacques;
    • Côté, Jean-François;
    • Labbé, David P.;
    • Lamarche-Vane, Nathalie
    Publication type:
    Article
    50